DNA diagnosis and the emergence of cancer-genetic services in european health care
Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Standard
DNA diagnosis and the emergence of cancer-genetic services in european health care. / Bourret, Pascale; Koch, Lene; Stemerding, Dirk.
The Social Management of Genetic Engineering. Taylor and Francis/Routledge, 2019. p. 117-138.Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - DNA diagnosis and the emergence of cancer-genetic services in european health care
AU - Bourret, Pascale
AU - Koch, Lene
AU - Stemerding, Dirk
PY - 2019
Y1 - 2019
N2 - This chapter focuses on cancer genetics as a field in which the extension of options for genetic testing is already clearly visible and which thus allows to study the implications of this development on an empirical level. It presents the introduction of deoxyribonucleic acid (DNA) diagnosis in the clinic as a complex process of sociotechnical change in which technical innovation is going together with the development of new skills, new relations between the clinic and the laboratory, new relations between professions, new forms of demand, new guidelines. In the context of established screening programmes for familial adenomatous polyposis, the introduction of DNA diagnosis in the early 1990s was generally seen as an opportunity to improve the organization of screening. The introduction of DNA diagnosis of hereditary breast and/or ovarian cancer is linked to initiatives which will further enhance awareness of familial breast and/or ovarian cancer risks and which will also generate increasing demand for a DNA diagnostic test.
AB - This chapter focuses on cancer genetics as a field in which the extension of options for genetic testing is already clearly visible and which thus allows to study the implications of this development on an empirical level. It presents the introduction of deoxyribonucleic acid (DNA) diagnosis in the clinic as a complex process of sociotechnical change in which technical innovation is going together with the development of new skills, new relations between the clinic and the laboratory, new relations between professions, new forms of demand, new guidelines. In the context of established screening programmes for familial adenomatous polyposis, the introduction of DNA diagnosis in the early 1990s was generally seen as an opportunity to improve the organization of screening. The introduction of DNA diagnosis of hereditary breast and/or ovarian cancer is linked to initiatives which will further enhance awareness of familial breast and/or ovarian cancer risks and which will also generate increasing demand for a DNA diagnostic test.
U2 - 10.4324/9780429423499-7
DO - 10.4324/9780429423499-7
M3 - Book chapter
AN - SCOPUS:33645774810
SN - 9780429423499
SP - 117
EP - 138
BT - The Social Management of Genetic Engineering
PB - Taylor and Francis/Routledge
ER -
ID: 241102838